FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285202293> ?p ?o ?g. }

• W4285202293 endingPage "205435812210987" @default.
• W4285202293 startingPage "205435812210987" @default.
• W4285202293 abstract "Background: End-stage kidney disease patients on dialysis have a substantial risk of polypharmacy due their propensity for comorbidity and contact with the health care system. MedSafer is an electronic decision support tool that integrates patient comorbidity and medication lists to generate personalized deprescribing reports focused on identifying potentially inappropriate medications (PIMs). Objective: To conduct a secondary analysis of patients on regular hemodialysis included in the MedSafer randomized controlled trial to investigate the patterns of polypharmacy and evaluate the efficacy of the MedSafer deprescribing algorithms. Design: Secondary analysis of a cluster randomized clinical trial. Setting: Medical units in 11 acute care hospitals in Canada. Patients: The MedSafer trial enrolled 5698 participants with an expected prognosis of >3 months, age 65 years and older, and on 5 or more daily home medications; 140 participants were receiving chronic hemodialysis. Measurements: The primary outcome of the trial was 30-day adverse drug events (ADEs) post-hospital discharge, and a key secondary outcome was deprescribing. Methods: Control patients received usual care (medication reconciliation), whereas clinicians caring for intervention patients received a MedSafer report that highlighted individualized opportunities for deprescribing. Results: There were 70 patients in each of the control and intervention arms. The median number of home medications was 14 (compared with a median of 10 medications in the general trial population). The most frequent medications observed that were potentially inappropriate were proton pump inhibitors (potentially inappropriate in 55/76 users; 72.4%), diabetes medications in patients with a HBA1C <7.5% (36/65 users; 55.4%), docusate (27/27 users; 100%), gabapentinoids (27/36 users; 75%), and combination antiplatelet/anticoagulants (22/97 users; 22.7%). The proportion of PIMs deprescribed was higher during the intervention phase (28.8% vs 19.3%; absolute increase 9.4% [95% confidence interval 1.3%-17.6%]) compared with the control phase. There was no observed difference in ADEs at 30-day post-discharge between the control and the intervention groups. The most common ADE (n = 3) was gastrointestinal bleeding attributed to antiplatelet agents. Limitations: This was a post hoc exploratory analysis, the original trial did not stratify by hemodialysis status, and the small sample size precludes drawing any definitive conclusions. Conclusion: MedSafer facilitates deprescribing in hospitalized patients on hemodialysis. Larger-scale implementation of decision support software for deprescribing in dialysis and long-term follow-up are likely required to demonstrate an impact on ADEs." @default.
• W4285202293 created "2022-07-14" @default.
• W4285202293 creator A5040595008 @default.
• W4285202293 creator A5056802196 @default.
• W4285202293 creator A5067653699 @default.
• W4285202293 creator A5071937316 @default.
• W4285202293 creator A5083860973 @default.
• W4285202293 creator A5087904889 @default.
• W4285202293 date "2022-01-01" @default.
• W4285202293 modified "2023-09-27" @default.
• W4285202293 title "Deprescribing Opportunities for Hospitalized Patients With End-Stage Kidney Disease on Hemodialysis: A Secondary Analysis of the MedSafer Cluster Randomized Controlled Trial" @default.
• W4285202293 cites W1965675690 @default.
• W4285202293 cites W1990232713 @default.
• W4285202293 cites W2025282593 @default.
• W4285202293 cites W2062096263 @default.
• W4285202293 cites W2088830915 @default.
• W4285202293 cites W2098891980 @default.
• W4285202293 cites W2108786753 @default.
• W4285202293 cites W2113760558 @default.
• W4285202293 cites W2126679895 @default.
• W4285202293 cites W2130510785 @default.
• W4285202293 cites W2149030597 @default.
• W4285202293 cites W2164249826 @default.
• W4285202293 cites W2166551141 @default.
• W4285202293 cites W2331366497 @default.
• W4285202293 cites W2465454303 @default.
• W4285202293 cites W2470481127 @default.
• W4285202293 cites W2559732081 @default.
• W4285202293 cites W2582602949 @default.
• W4285202293 cites W2605738993 @default.
• W4285202293 cites W2619905550 @default.
• W4285202293 cites W2763920048 @default.
• W4285202293 cites W2790248198 @default.
• W4285202293 cites W2806922111 @default.
• W4285202293 cites W2904281537 @default.
• W4285202293 cites W2954253497 @default.
• W4285202293 cites W3020956628 @default.
• W4285202293 cites W3037026771 @default.
• W4285202293 cites W3096195021 @default.
• W4285202293 cites W3096288082 @default.
• W4285202293 cites W3112406393 @default.
• W4285202293 cites W3139528122 @default.
• W4285202293 cites W3155338345 @default.
• W4285202293 cites W3208869615 @default.
• W4285202293 cites W4205337584 @default.
• W4285202293 cites W4206668990 @default.
• W4285202293 cites W4211210745 @default.
• W4285202293 doi "https://doi.org/10.1177/20543581221098778" @default.
• W4285202293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35586025" @default.
• W4285202293 hasPublicationYear "2022" @default.
• W4285202293 type Work @default.
• W4285202293 citedByCount "3" @default.
• W4285202293 countsByYear W42852022932022 @default.
• W4285202293 countsByYear W42852022932023 @default.
• W4285202293 crossrefType "journal-article" @default.
• W4285202293 hasAuthorship W4285202293A5040595008 @default.
• W4285202293 hasAuthorship W4285202293A5056802196 @default.
• W4285202293 hasAuthorship W4285202293A5067653699 @default.
• W4285202293 hasAuthorship W4285202293A5071937316 @default.
• W4285202293 hasAuthorship W4285202293A5083860973 @default.
• W4285202293 hasAuthorship W4285202293A5087904889 @default.
• W4285202293 hasBestOaLocation W42852022931 @default.
• W4285202293 hasConcept C126322002 @default.
• W4285202293 hasConcept C168563851 @default.
• W4285202293 hasConcept C177713679 @default.
• W4285202293 hasConcept C187212893 @default.
• W4285202293 hasConcept C194828623 @default.
• W4285202293 hasConcept C197934379 @default.
• W4285202293 hasConcept C2776484012 @default.
• W4285202293 hasConcept C2778063415 @default.
• W4285202293 hasConcept C2778653478 @default.
• W4285202293 hasConcept C2779159551 @default.
• W4285202293 hasConcept C2779978075 @default.
• W4285202293 hasConcept C2908647359 @default.
• W4285202293 hasConcept C3019040382 @default.
• W4285202293 hasConcept C36434225 @default.
• W4285202293 hasConcept C71924100 @default.
• W4285202293 hasConcept C99454951 @default.
• W4285202293 hasConceptScore W4285202293C126322002 @default.
• W4285202293 hasConceptScore W4285202293C168563851 @default.
• W4285202293 hasConceptScore W4285202293C177713679 @default.
• W4285202293 hasConceptScore W4285202293C187212893 @default.
• W4285202293 hasConceptScore W4285202293C194828623 @default.
• W4285202293 hasConceptScore W4285202293C197934379 @default.
• W4285202293 hasConceptScore W4285202293C2776484012 @default.
• W4285202293 hasConceptScore W4285202293C2778063415 @default.
• W4285202293 hasConceptScore W4285202293C2778653478 @default.
• W4285202293 hasConceptScore W4285202293C2779159551 @default.
• W4285202293 hasConceptScore W4285202293C2779978075 @default.
• W4285202293 hasConceptScore W4285202293C2908647359 @default.
• W4285202293 hasConceptScore W4285202293C3019040382 @default.
• W4285202293 hasConceptScore W4285202293C36434225 @default.
• W4285202293 hasConceptScore W4285202293C71924100 @default.
• W4285202293 hasConceptScore W4285202293C99454951 @default.
• W4285202293 hasLocation W42852022931 @default.
• W4285202293 hasLocation W42852022932 @default.
• W4285202293 hasLocation W42852022933 @default.
• W4285202293 hasLocation W42852022934 @default.

• next